DOCSLIB.ORG

MBL and L-Ficolin Levels and Genotypes in Community-Acquired Pneumonia

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MBL and L-Ficolin Levels and Genotypes in Community-Acquired Pneumonia MBL and L-ficolin levels and genotypes in community-acquired pneumonia MBL and L-ficolin: levels and genotypes in community-acquired pneumonia Thesis, Utrecht University, The Netherlands Printed by Wöhrmann Print Service, Zuthpen ISBN 978-90-8570-734-9 Printing of this thesis was financially supported by the Infection & Immunity Center Utrecht, the Netherlands Society of Medical Microbiology (NVMM) and the Netherlands Society for Microbiology (NVvM), Bayer HealthCare, BD Diagnostics, DiaSorin, Gilead Sciences Netherlands, Mediphos Medical Supplies, Merck Sharp & Dohme, Meridian Biosciences Europe and Pfizer. MBL and L-ficolin levels and genotypes in community-acquired pneumonia MBL en L-ficolin spiegels en genotypen bij thuis opgelopen longontsteking (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof.dr. G.J. van der Zwaan, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op donderdag 21 april 2011 des ochtends te 10.30 uur door Bjorn Lars Herpers geboren op 16 februari 1974 te Schaesberg Promotoren: Prof.dr. J. Verhoef Prof.dr. J.A.G van Strijp Co-promotoren: Dr. B.M. de Jongh Dr. G.T. Rijkers CONTENTS Glossary 8 Chapter 1 11 General introduction Chapter 2 49 Coding and non-coding polymorphisms in the lectin pathway activator L-ficolin gene in 188 Dutch blood bank donors Chapter 3 59 Hemolytic assay for the measurement of functional human mannose-binding lectin: A modification to avoid interference from classical pathway activation Chapter 4 67 Mannose-binding lectin genotypes in susceptibility to community- acquired pneumonia Chapter 5 81 Deficient mannose-binding lectin-mediated complement activation despite mannose-binding lectin-sufficient genotypes in an outbreak of Legionella pneumophila pneumonia Chapter 6 93 Acute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypes Chapter 7 105 L-ficolin acts as an acute phase reactant in community-acquired pneumonia Chapter 8 117 Discussion Chapter 9 131 Summary / Samenvatting Chapter 10 135 Curriculum vitae Chapter 11 139 Dankwoord Chapter 12 143 List of publications GLOSSARY Adaptive immunity Those cells, molecules and mechanisms of the immune system that act on danger signals in an antigen-specific manner. The adaptive immune system recognizes pathogens through specific antigenic epitopes associated with a pathogen. Responses in adaptive immunity are shaped over time by repeated challenge, becoming more targeted and they posses mechanisms of memory of earlier immune responses by memory cells. It is the counterpart of innate immunity. Allele A particular DNA sequence of a gene. When a gene is polymorphic, the genetic variants are called alleles. Complement A system of more than 30 fluid phase and cell-associated components, which act in a cascade-like network that is involved in opsonization and lysis of microbes, cellular recruitment and activation, and immune clearance of immune complexes. The complement system is part of the innate immune system and can be triggered by components of both innate and adaptive immunity. Ficolins A group of proteins that share the structure of a collagenous triple helix and a fibrinogen-like C-terminal domain. They are found in a wide range of species. Human ficolins L-ficolin, H-ficolin and M- ficolin resemble MBL in structure and function. FCN2 The gene encoding human L-ficolin. Genotype The genetic constitution. Since humans are diploid and carry two copies of each gene on two homologous chromosomes, the genotype refers to the combination of two alleles or haplotypes. Haplotype A combination of co-occurring SNPs that are located at different sites on a gene. Haplotypes represent the fact that genetic variations at different sites of a gene are linked because they are situated on the same DNA fragment. Heterozygous Carrying different alleles of a gene on the two homologous chromosomes. Homozygous Carrying identical alleles of a gene on both homologous chromosomes. Innate immunity Those cells, molecules and mechanisms of the immune system that act on danger signals in a non-specific, generic manner. The innate immune system recognizes pathogens through evolutionary conserved general patterns associated with these pathogens. Responses in innate immunity are fixed, as they are not further shaped by repeated challenge and they do not posses mechanisms of memory of earlier immune responses. It is the counterpart of adaptive immunity. MASP MBL-associated serine protease. MASPs bind to MBL and ficolins. With their serine protease domains, MASP-2 and MASP-1 enzymatically cleave complement components C4 and C2, setting of the complement cascade. MASP-3 and the splicing variants Map44 and Map19 do not show this enzymatic activity and are thought to have a regulatory role. MBL Mannose-binding lectin. MBL is a multimeric pattern recognition receptor circulating in plasma that binds to invading pathogens and activates the complement system. Proteins similar to MBL are found in a wide range of species. MBL2 The gene encoding MBL. Multimeric Consisting of multiple subunits, called monomers. Higher order multimers consist of many monomeric subunits, while lower order multimers or oligomers consist of a few. Polymorphism The occurrence of more than one allele of a gene within a population, representing genetic diversity in a population. SNP Single nucleotide polymorphism (SNP, pronounced as “snip”). A DNA sequence variation consisting of only one variant nucleotide. 1 General introduction General introduction Lung immune defenses To resist the constant challenge of potentially infectious agents, the lungs posses innate and adaptive immune defense mechanisms that prevent colonization and clear invading pathogens (Figure 1).1 Structural defenses form the first barrier for invading pathogens. The anatomical design of the nose causes such an airflow that large particles (>5µm) are caught on the nasal mucosa before entering the lower airways. Smaller particles can be trapped in the mucus overlying the respiratory epithelium. By the coordinated movement of the underlying cilia, mucus and particles are removed mechanically by forcing them towards the mouth. The cough and sneeze reflexes also help to remove depositions from the airways.2 If pathogens succeed in passing through physical and mechanical barriers, the innate immune system is called upon. Soluble antimicrobial molecules including the various components of the complement system, alveolar macrophages, neutrophils, natural killer cells and dendritic cells are active in the first minutes of colonization and invasion. They restrain infection by their intrinsic antimicrobial activity and the regulation of inflammation and activation of the adaptive immune response. Soluble enzymes like lysozyme and peroxidase posses antibacterial activity. Defensins are secreted by epithelial cells and neutrophils and posses activity against Gram-positive and Gram-negative bacteria, mycobacteria, fungi and viruses.3 They bind to the microbial cell membrane, forming pores that lead to lysis of the cells. Pentraxins such as C-reactive protein (CRP), serum amyloid P and PTX3 bind to microbial structures, thus opsonizing microbes for phagocytosis and complement mediated lysis.4 The complement system consists of more than 30 fluid phase and cell-associated components, which act in a cascade-like network that plays a pivotal role in innate immunity, as it is involved in opsonization and lysis of microbes, cellular recruitment and activation, and immune clearance of immune complexes. The complement system can be triggered by components of innate and adaptive immunity.5,6 The most well-known activator of complement in innate immunity is mannose-binding lectin (MBL), a plasma protein belonging to the collectin family. Collectins are oligomeric proteins with a collagenous region and C-type lectin domains, capable of binding saccharide moieties on microbial surfaces.7 The collectins surfactant proteins A and D are found in high concentrations in the alveoli of the lungs, functioning as opsonins and agglutinins of pathogens in the lower airways. MBL not only opsonizes microbes for phagocytosis, but subsequently can activate the complement system as well. The ficolins share some structural and functional properties with MBL. Instead of recognizing microbial structures through a C-type lectin domain, they possess a fibrinogen-like domain binding to acetylated moieties also found on microbes.8,9 Binding of ficolins leads to opsonization and complement activation as well.10 The complement system, as well as its activators MBL and the ficolins, will be discussed in more detail below. Besides soluble components, the innate immune system also encompasses cellular elements. In the lungs, alveolar macrophages and neutrophils can kill invading microbes via phagocytosis and subsequent production of reactive oxygen species and lytic General introduction | 13 invading pathogen immune system upper airway lysozyme peroxidase direct pathogen death lactoferrin defensins neutrophils phagocytosis lower airways macrophages reactive oxygen species defensins lysosomal enzymes direct pathogen death complement activation collectins ficolins complement activation pentraxins induction of adaptive immune response dendritic cells T cells B cells pathogen evasion and survival clearance of pathogen Figure 1 | Pulmonary defences against invading pathogens
Load more

Recommended publications
  • Variation in FCN1 Affects Biosynthesis of Ficolin-1 and Is Associated With
    Genes and Immunity (2012) 13, 515–522 & 2012 Macmillan Publishers Limited All rights reserved 1466-4879/12 www.nature.com/gene ORIGINAL ARTICLE Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation L Munthe-Fog1, T Hummelshoj1, C Honore´ 1, ME Moller1, MO Skjoedt1, I Palsgaard1, N Borregaard2, HO Madsen1 and P Garred1 Ficolin-1 is a recognition molecule of the lectin complement pathway. The ficolin-1 gene FCN1 is polymorphic, but the functional and clinical consequences are unknown.The concentration of ficolin-1 in plasma and FCN1 polymorphisms in positions À 1981 (rs2989727), À 791 (rs28909068), À 542 (rs10120023), À 271 (rs28909976), À 144 (rs10117466) and þ 7918 (rs1071583) were determined in 100 healthy individuals. FCN1 expression by isolated monocytes and granulocytes and ficolin-1 levels in monocyte culture supernatants were assessed in 21 FCN1-genotyped individuals. FCN1 polymorphisms were determined in a cohort of 251 patients with systemic inflammation. High ficolin-1 plasma levels were significantly associated with the minor alleles in position À 542 and À 144. These alleles were also significantly associated with high FCN1 mRNA expression. The level of ficolin-1 in culture supernatants was significantly higher in individuals homozygous for the minor alleles at positions À 542 and À 144. Homozygosity for these alleles was significantly associated with fatal outcome in patients with systemic inflammation. None of the other investigated polymorphisms were associated with FCN1 and ficolin-1 expression, concentration or disease outcome. Functional polymorphic sites in the promoter region of FCN1 regulate both the expression and synthesis of ficolin-1 and are associated with outcome in severe inflammation.
    [Show full text]
  • Complement Recognition Pathways in Renal Transplantation
    BRIEF REVIEW www.jasn.org Complement Recognition Pathways in Renal Transplantation Christopher L. Nauser, Conrad A. Farrar, and Steven H. Sacks Medical Research Council Centre for Transplantation, Division of Transplantation Immunology and Mucosal Biology, King’s College London, National Health Service Guy’s and St. Thomas’ Trust, London, United Kingdom ABSTRACT The complement system, consisting of soluble and cell membrane–bound compo- weigh its effect on organ injury and nents of the innate immune system, has defined roles in the pathophysiology of renal rejection with dampening the antimi- allograft rejection. Notably, the unavoidable ischemia-reperfusion injury inherent to crobial functions of the complement sys- transplantation is mediated through the terminal complement activation products tem, such as opsonisation, cell lysis, and C5a and C5b-9. Furthermore, biologically active fragments C3a and C5a, produced recruitment of neutrophils and other in- during complement activation, can modulate both antigen presentation and T cell flammatory cells.7 It is our belief that priming, ultimately leading to allograft rejection. Earlier work identified renal tubule therapeutic strategies can be designed cell synthesis of C3, rather than hepatic synthesis of C3, as the primary source of C3 to specificallytargetthekeyinitiators driving these effects. Recent efforts have focused on identifying the local triggers of of complement activation at the relevant complement activation. Collectin-11, a soluble C-type lectin expressed in renal tis- location, such as complement-binding sue, has been implicated as an important trigger of complement activation in renal anti-HLA antibodies in the vascular tissue. In particular, collectin-11 has been shown to engage L-fucose at sites of compartment or the initiator(s) of local ischemic stress, activating the lectin complement pathway and directing the innate complement activation in the extravas- immune response to the distressed renal tubule.
    [Show full text]
  • Chromosomal Aberrations in Head and Neck Squamous Cell Carcinomas in Norwegian and Sudanese Populations by Array Comparative Genomic Hybridization
    825-843 12/9/08 15:31 Page 825 ONCOLOGY REPORTS 20: 825-843, 2008 825 Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization ERIC ROMAN1,2, LEONARDO A. MEZA-ZEPEDA3, STINE H. KRESSE3, OLA MYKLEBOST3,4, ENDRE N. VASSTRAND2 and SALAH O. IBRAHIM1,2 1Department of Biomedicine, Faculty of Medicine and Dentistry, University of Bergen, Jonas Lies vei 91; 2Department of Oral Sciences - Periodontology, Faculty of Medicine and Dentistry, University of Bergen, Årstadveien 17, 5009 Bergen; 3Department of Tumor Biology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello, 0310 Oslo; 4Department of Molecular Biosciences, University of Oslo, Blindernveien 31, 0371 Oslo, Norway Received January 30, 2008; Accepted April 29, 2008 DOI: 10.3892/or_00000080 Abstract. We used microarray-based comparative genomic logical parameters showed little correlation, suggesting an hybridization to explore genome-wide profiles of chromosomal occurrence of gains/losses regardless of ethnic differences and aberrations in 26 samples of head and neck cancers compared clinicopathological status between the patients from the two to their pair-wise normal controls. The samples were obtained countries. Our findings indicate the existence of common from Sudanese (n=11) and Norwegian (n=15) patients. The gene-specific amplifications/deletions in these tumors, findings were correlated with clinicopathological variables. regardless of the source of the samples or attributed We identified the amplification of 41 common chromosomal carcinogenic risk factors. regions (harboring 149 candidate genes) and the deletion of 22 (28 candidate genes). Predominant chromosomal alterations Introduction that were observed included high-level amplification at 1q21 (harboring the S100A gene family) and 11q22 (including Head and neck squamous cell carcinoma (HNSCC), including several MMP family members).
    [Show full text]
  • SPP1 and AGER As Potential Prognostic Biomarkers for Lung Adenocarcinoma
    7028 ONCOLOGY LETTERS 15: 7028-7036, 2018 SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma WEIGUO ZHANG, JUNLI FAN, QIANG CHEN, CAIPENG LEI, BIN QIAO and QIN LIU Henan Key Laboratory of Cancer Epigenetics, Department of Oncology Surgery, Cancer Institute and College of Clinical Medicine, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China Received August 11, 2017; Accepted January 5, 2018 DOI: 10.3892/ol.2018.8235 Abstract. Overdue treatment and prognostic evaluation lead Introduction to low survival rates in patients with lung adenocarcinoma (LUAD). To date, effective biomarkers for prognosis are still Lung adenocarcinoma (LUAD) is one of the three major required. The aim of the present study was to screen differen- histopathological subtypes along with squamous cell carci- tially expressed genes (DEGs) as biomarkers for prognostic noma (SqCLC) and large cell carcinoma (1). Currently, LUAD evaluation of LUAD. DEGs in tumor and normal samples has become the most common lung cancer with increasing were identified and analyzed for Kyoto Encyclopedia of Genes morbidity. This uptrend of incidence may be due to increasing and Genomes/Gene Ontology functional enrichments. The smoking rate and air pollution (2). Furthermore, LUAD is common genes that are up and downregulated were selected diagnosed at late stages (stage III and IV), when the cancer for prognostic analysis using RNAseq data in The Cancer has spread to nearby tissues and metastasis has occurred (3). Genome Atlas. Differential expression analysis was performed As well as overdue diagnosis that leads to delayed treatment, with 164 samples in GSE10072 and GSE7670 datasets.
    [Show full text]
  • Activation Regulates Alternative Pathway Complement Necrotic
    Properdin Binds to Late Apoptotic and Necrotic Cells Independently of C3b and Regulates Alternative Pathway Complement Activation This information is current as of September 27, 2021. Wei Xu, Stefan P. Berger, Leendert A. Trouw, Hetty C. de Boer, Nicole Schlagwein, Chantal Mutsaers, Mohamed R. Daha and Cees van Kooten J Immunol 2008; 180:7613-7621; ; doi: 10.4049/jimmunol.180.11.7613 Downloaded from http://www.jimmunol.org/content/180/11/7613 References This article cites 56 articles, 27 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/180/11/7613.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 27, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Properdin Binds to Late Apoptotic and Necrotic Cells Independently of C3b and Regulates Alternative Pathway Complement Activation1,2 Wei Xu,* Stefan P. Berger,* Leendert A.
    [Show full text]
  • 13-Van Lieshout TOORTHJ
    Send Orders for Reprints to [email protected] The Open Orthopaedics Journal, 2015, 9, (Suppl 1: M13) 367-371 367 Open Access Multiple Infectious Complications in a Severely Injured Patient with Single Nucleotide Polymorphisms in Important Innate Immune Response Genes Maarten W.G.A. Bronkhorst1, Peter Patka2 and Esther M.M. Van Lieshout*,1 1Trauma Research Unit Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands 2Department of Accident & Emergency, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands Abstract: Trauma is a major public health problem worldwide. Infectious complications, sepsis, and multiple organ dysfunction syndrome (MODS) remain important causes for morbidity and mortality in patients who survive the initial trauma. There is increasing evidence for the role of genetic variation in the innate immune system on infectious complications in severe trauma patients. We describe a trauma patient with multiple infectious complications caused by multiple micro-organisms leading to prolonged hospital stay with numerous treatments. This patient had multiple single nucleotide polymorphisms (SNPs) in the MBL2, MASP2, FCN2 and TLR2 genes, most likely contributing to increased susceptibility and severity of infectious disease. Keywords: Complications, genetic variation, infection, multiple organ dysfunction syndrome, single nucleotide polymorphism, systemic inflammatory response syndrome, trauma. INTRODUCTION differences between humans These differences are known as ‘polymorphisms’. The coding regions of DNA contain the Trauma is a major public health problem worldwide, approximately 20,000 human protein-coding genes. The ranking as the fourth leading cause of death. In 2010, there coding regions take up less than 2% of all DNA. More than were 5.1 million deaths from injuries and the total number of 98% of the human genome is composed of non-coding DNA deaths from injuries was greater than the number of deaths of which the function is partly unknown.
    [Show full text]
  • An Anticomplement Agent That Homes to the Damaged Brain and Promotes Recovery After Traumatic Brain Injury in Mice
    An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice Marieta M. Rusevaa,1,2, Valeria Ramagliab,1, B. Paul Morgana, and Claire L. Harrisa,3 aInstitute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff CF14 4XN, United Kingdom; and bDepartment of Genome Analysis, Academic Medical Center, Amsterdam 1105 AZ, The Netherlands Edited by Douglas T. Fearon, Cornell University, Cambridge, United Kingdom, and approved September 29, 2015 (received for review July 15, 2015) Activation of complement is a key determinant of neuropathology to rapidly and specifically inhibit MAC at sites of complement and disability after traumatic brain injury (TBI), and inhibition is activation, and test its therapeutic potential in experimental TBI. neuroprotective. However, systemic complement is essential to The construct, termed CD59-2a-CRIg, comprises CD59a linked fight infections, a critical complication of TBI. We describe a to CRIg via the murine IgG2a hinge. CD59a prevents assembly targeted complement inhibitor, comprising complement receptor of MAC in cell membranes (16), whereas CRIg binds C3b/iC3b of the Ig superfamily (CRIg) fused with complement regulator CD59a, deposited at sites of complement activation (17). The IgG2a designed to inhibit membrane attack complex (MAC) assembly at hinge promotes dimerization to increase ligand avidity. CD59- sites of C3b/iC3b deposition. CRIg and CD59a were linked via the 2a-CRIg protected in the TBI model, demonstrating that site- IgG2a hinge, yielding CD59-2a-CRIg dimer with increased iC3b/C3b targeted anti-MAC therapeutics may be effective in prevention binding avidity and MAC inhibitory activity. CD59-2a-CRIg inhibited of secondary neuropathology and improve neurologic recovery MAC formation and prevented complement-mediated lysis in vitro.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Complement Inactivation Strategy of Staphylococcus Aureus Using Decay-Accelerating Factor and the Response of Infected Hacat Cells
    International Journal of Molecular Sciences Article Complement Inactivation Strategy of Staphylococcus aureus Using Decay-Accelerating Factor and the Response of Infected HaCaT Cells Kyoung Ok Jang 1, Youn Woo Lee 1, Hangeun Kim 2,* and Dae Kyun Chung 1,2,3,* 1 Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Korea; [email protected] (K.O.J.); [email protected] (Y.W.L.) 2 Research and Development Center, Skin Biotechnology Center Inc., Yongin 17104, Korea 3 Skin Biotechnology Center, Kyung Hee University, Suwon 16229, Korea * Correspondence: [email protected] (H.K.); [email protected] (D.K.C.); Tel.: +82-31-201-2487 (H.K.); +82-31-888-6170 (D.K.C.) Abstract: Staphylococcus aureus is a species of Gram-positive staphylococcus. It can cause sinusitis, respiratory infections, skin infections, and food poisoning. Recently, it was discovered that S. aureus infects epithelial cells, but the interaction between S. aureus and the host is not well known. In this study, we confirmed S. aureus to be internalized by HaCaT cells using the ESAT-6-like protein EsxB and amplified within the host over time by escaping host immunity. S. aureus increases the expression of decay-accelerating factor (CD55) on the surfaces of host cells, which inhibits the activation of the complement system. This mechanism makes it possible for S. aureus to survive in host cells. S. aureus, sufficiently amplified within the host, is released through the initiation of cell death. On the other hand, the infected host cells increase their surface expression of UL16 binding protein 1 to inform Citation: Jang, K.O.; Lee, Y.W.; Kim, immune cells that they are infected and try to be eliminated.
    [Show full text]
  • The Complement System: a Powerful Modulator and Effector of Astrocyte Function in the Healthy and Diseased Central Nervous System
    cells Review The Complement System: A Powerful Modulator and Effector of Astrocyte Function in the Healthy and Diseased Central Nervous System Marcela Pekna 1,3,4,* and Milos Pekny 2,3,4 1 Laboratory of Regenerative Neuroimmunology, Center for Brain Repair, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, 40530 Gothenburg, Sweden 2 Laboratory of Astrocyte Biology and CNS Regeneration, Center for Brain Repair, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, 40530 Gothenburg, Sweden; [email protected] 3 Florey Institute of Neuroscience and Mental Health, Parkville, Melbourne 3010, Australia 4 School of Medicine and Public Health, University of Newcastle, Newcastle 2308, Australia * Correspondence: [email protected]; Tel.: +46-31-786-3581 Abstract: The complement system, an effector arm of the innate immune system that plays a critical role in tissue inflammation, the elimination of pathogens and the clearance of dead cells and cell debris, has emerged as a regulator of many processes in the central nervous system, including neural cell genesis and migration, control of synapse number and function, and modulation of glial cell responses. Complement dysfunction has also been put forward as a major contributor to neurological disease. Astrocytes are neuroectoderm-derived glial cells that maintain water and ionic homeostasis, and control cerebral blood flow and multiple aspects of neuronal functioning. By virtue of their Citation: Pekna, M.; Pekny, M. The Complement System: A Powerful expression of soluble as well as membrane-bound complement proteins and receptors, astrocytes are Modulator and Effector of Astrocyte able to both send and receive complement-related signals.
    [Show full text]
  • Human Lectins, Their Carbohydrate Affinities and Where to Find Them
    biomolecules Review Human Lectins, Their Carbohydrate Affinities and Where to Review HumanFind Them Lectins, Their Carbohydrate Affinities and Where to FindCláudia ThemD. Raposo 1,*, André B. Canelas 2 and M. Teresa Barros 1 1, 2 1 Cláudia D. Raposo * , Andr1 é LAQVB. Canelas‐Requimte,and Department M. Teresa of Chemistry, Barros NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829‐516 Caparica, Portugal; [email protected] 12 GlanbiaLAQV-Requimte,‐AgriChemWhey, Department Lisheen of Chemistry, Mine, Killoran, NOVA Moyne, School E41 of ScienceR622 Co. and Tipperary, Technology, Ireland; canelas‐ [email protected] NOVA de Lisboa, 2829-516 Caparica, Portugal; [email protected] 2* Correspondence:Glanbia-AgriChemWhey, [email protected]; Lisheen Mine, Tel.: Killoran, +351‐212948550 Moyne, E41 R622 Tipperary, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +351-212948550 Abstract: Lectins are a class of proteins responsible for several biological roles such as cell‐cell in‐ Abstract:teractions,Lectins signaling are pathways, a class of and proteins several responsible innate immune for several responses biological against roles pathogens. such as Since cell-cell lec‐ interactions,tins are able signalingto bind to pathways, carbohydrates, and several they can innate be a immuneviable target responses for targeted against drug pathogens. delivery Since sys‐ lectinstems. In are fact, able several to bind lectins to carbohydrates, were approved they by canFood be and a viable Drug targetAdministration for targeted for drugthat purpose. delivery systems.Information In fact, about several specific lectins carbohydrate were approved recognition by Food by andlectin Drug receptors Administration was gathered for that herein, purpose. plus Informationthe specific organs about specific where those carbohydrate lectins can recognition be found by within lectin the receptors human was body.
    [Show full text]
  • Original Article Regulation of Gene Expression in HBV- and HCV-Related Hepatocellular Carcinoma: Integrated GWRS and GWGS Analyses
    Int J Clin Exp Med 2014;7(11):4038-4050 www.ijcem.com /ISSN:1940-5901/IJCEM0002458 Original Article Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses Xu Zhou*, Hua-Qiang Zhu*, Jun Lu Department of General Surgery, Provincial Hospital Affiliated to Shandong University, Ji’nan 250014, China. *Equal contributors and co-first authors. Received September 11, 2014; Accepted November 8, 2014; Epub November 15, 2014; Published November 30, 2014 Abstract: Objectives: To explore the molecular mechanism of hepatitis B virus-related and hepatitis C virus-related hepatocellular carcinoma, samples from hepatitis B virus and hepatitis C virus infected patients and the normal were compared, respectively. Methods: In both experiments, genes with high value were selected based on a ge- nome-wide relative significance and genome-wide global significance model. Co-expression network of the selected genes was constructed, and transcription factors in the network were identified. Molecular complex detection al- gorithm was used to obtain sub-networks. Results: Based on the new model, the top 300 genes were selected. Co-expression network was constructed and transcription factors were identified. We obtained two common genes FCN2 and CXCL14, and two common transcription factors RFX5 and EZH2. In hepatitis B virus experiment, cluster 1 and 3 had the higher value. In cluster 1, ten of the 17 genes and one transcription factor were all reported associ- ated with hepatocellular carcinoma. In cluster 3, transcription factor ESR1 was reported related with hepatocellular carcinoma. In hepatitis C virus experiment, the value of cluster 3 and 4 was higher.
    [Show full text]